Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

64244

	registered interest
	date	26/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Illness: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how they will assess the level of care provided by Public Health England and local charities to help those suffering from addiction to, and withdrawal from, psychiatric drugs; and whether they have estimated the number of those afflicted.
	tabling member printed	The Earl of Sandwich
	uin	HL646
	answer	answer is ministerial correction date of answer 09/07/2014 answer text <p>Public Health England does not provide care, its role is to support commissioners to better understand and address local drug need. If local addiction charities are commissioned by a local authority, then it is the responsibility of local commissioners to assess the level of care they provide. If they are registered with the Care Quality Commission then they will be expected to meet minimum care standards.</p><p> </p><p>There is no widely accepted definition of ‘psychiatric drugs'. In-depth research commissioned by the Department found that there are no national databases that can give us information on the number of people who are addicted to medicine.</p><p> </p> answering member printed Earl Howe question first answered 09/07/2014 15:14:26 answering member 2000 label Biography information for Earl Howe
	tabling member	2109 label Biography information for The Earl of Sandwich

62487

	registered interest
	date	18/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks and Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the number of people currently damaged by alcohol and drug abuse in the United Kingdom.
	tabling member printed	The Earl of Dundee
	uin	HL416
	answer	answer is ministerial correction date of answer 01/07/2014 answer text <p>The United Kingdom Drug Policy Commission collect data on the numbers affected by drug addiction and publish their findings in their report <em>Supporting the Supporters: families of drug misusers 2009.</em> The findings estimate that nearly 1.5 million people are affected by drug addiction in their families, mostly in poor communities.</p><p> </p><p>Estimates in the Office of National Statistics report ‘Deaths Related to Drug Poisoning in England and Wales, 2012 and Alcohol-related deaths in the UK, registered in 2012' showed that there were 1,496 drug misuse deaths in England.</p><p> </p><p>In England, data on the number of adults who report some signs of drug or alcohol dependence is published by theHealth and Social Care Information Centre, in the <em>Adult Psychiatric Morbidity in England, 2007 report</em>. The report includes information on rates of dependency and access to treatments. This data will be updated in 2014 and will be available in 2017.</p><p> </p><p>The Centre for Public Health, Liverpool John Moores University, published on 25 March, ‘Updating England-specific Alcohol-attributable Fractions', with revised estimates for England showing that over 21,000 people died in 2010 and that over 900,000 people were admitted to hospital in 2010-11 for alcohol-related causes.</p><p> </p><p>Public health prevention, treatment and care in Scotland, Wales and Northern Ireland is a matter for those Devolved Administrations. Each country maintains its own information. For example:</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>- In 2012-13 there were 5,683 drug related discharges from a general acute hospital in Scotland (a European age-sex-standardised rate (EASR) of 107 discharges per 100,000 population). The National Records of Scotland reported that there were 581 drug related deaths in 2012 in Scotland.</p><p> </p><p>- In 2012-13 there were 35,926 alcohol related discharges from a general acute hospital in Scotland (a European age-sex-standardised rate (EASR) of 693 discharges per 100,000 population).</p><p> </p><p>- There were 25,000 referrals for drug and alcohol misuse recorded in 2012 -13 on the Welsh National Database for Substance Misuse.</p><p> </p><p>- Data on the number of drug - related deaths in Northern Ireland is collected by the General Register Office and published in their annual report. The most recent estimates show that there were 110 drug related deaths in 2012.</p><p> </p><p>- Data on the number of drug and alcohol – related hospital admissions is collected by the Hospital Inpatient System in Northern Ireland. The most recent estimates show that there were 15,701 drug and alcohol admissions to hospitals in Northern Ireland.</p><p> </p><p>Data may not be comparable across the UK in all cases.</p> answering member printed Earl Howe question first answered 01/07/2014 11:39:40 answering member 2000 label Biography information for Earl Howe
	tabling member	2735 label Biography information for The Earl of Dundee

62488

	registered interest
	date	18/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks and Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is their current level of funding of charities and institutions that seek to reduce alcohol and drug abuse in the United Kingdom.
	tabling member printed	The Earl of Dundee
	uin	HL417
	answer	answer is ministerial correction date of answer 01/07/2014 answer text <p>The Innovation Excellence &amp; Strategic Development Fund (IESD) provides funding from one to three years to support proposals in the health and care field.</p><p> </p><p>A total of £658,902 has been awarded by the Department's IESD Fund in 2014-15 to organisations seeking to reduce alcohol and/or drug misuse. This amount is in respect of seven separate projects. The scope of the activity of these projects and the IESD Fund in general is within England only. The main responsibility for funding of services reducing alcohol and drug misuse is for local authorities. The Department does not hold detailed information on local funding.</p><p> </p><p>A significant proportion of alcohol and drug treatment services is provided by charities and voluntary organisations and is funded by local authorities though the public health grant.</p> answering member printed Earl Howe question first answered 01/07/2014 11:40:48 answering member 2000 label Biography information for Earl Howe
	tabling member	2735 label Biography information for The Earl of Dundee

62490

	registered interest
	date	18/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks and Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to co-operate with institutions and other governments to reduce alcohol and drug abuse internationally.
	tabling member printed	The Earl of Dundee
	uin	HL419
	answer	answer is ministerial correction date of answer 01/07/2014 answer text <p>We recognise the importance of international cooperation in preventing alcohol and drug misuse effectively.</p><p> </p><p>We continue to work with international partners, the United Nations, the European Union and through the British-Irish Council to promote the lessons the United Kingdom has learnt from its effective drugs strategy, and the benefits of a balanced, evidence based response within the international drug control conventions.</p><p> </p><p>The Treaty on the Functioning of the European Union recognises that Member States have the prime responsibility for public health, including preventing and reducing harm from alcohol, while the EU has a role to support Member States in this function. Discussions are currently taking place with Member States and the European Commission to develop:</p><p> </p><p>- A new EU Alcohol Action Plan on youth drinking and binge drinking to run from 2014 to 2016 within the current EU Alcohol Strategy; and</p><p>- ideas for a new EU Alcohol Strategy.</p><p> </p><p>The World Health Organization (WHO) has a leading role in further building the evidence base, the development of policy tools and the establishment and maintenance of a global information system on alcohol and health as set out in the WHO global alcohol strategy.</p><p> </p><p>The WHO UK Alcohol Focal Point which represents the UK, including the Devolved Administrations, is chair of the 53 European Alcohol Focal Points and sits on the WHO Global Co-ordinating Council for delivery of the global alcohol strategy.</p> answering member printed Earl Howe question first answered 01/07/2014 11:42:20 answering member 2000 label Biography information for Earl Howe
	tabling member	2735 label Biography information for The Earl of Dundee

64129

	registered interest
	date	25/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Staff
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many non-clinical or managerial staff were working in the National Health Service on (1) 1 April 2010, and (2) 1 April 2014.
	tabling member printed	The Earl of Courtown
	uin	HL633
	answer	answer is ministerial correction date of answer 03/07/2014 answer text <p>In the provisional monthly National Health Service hospital and community health service (HCHS) workforce statistics, published by the Health and Social Care Information Centre, the category of NHS Infrastructure Support Staff records the numbers of non-clinical staff working in the NHS in England. This includes administrative and clerical staff working in central functions; hotel, property and estates; as well as managers and senior managers.</p><p> </p><p>The numbers of NHS Infrastructure Support staff as at 31 March 2010 and 31 March 2014 are shown in the following table. The statistics for March 2014 are the latest available and therefore March 2010 data is also used to ease comparability. The April 2014 statistics will be published on 22 July 2014.</p><p> </p> answering member printed Earl Howe question first answered 03/07/2014 14:18:47 answering member 2000 label Biography information for Earl Howe attachment 1 file name HL633 - Lib Doc Table.xlsx title NHS Infastructure Support Staff, 2010 - 14
	tabling member	3359 label Biography information for The Earl of Courtown

65215

	registered interest
	date	01/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many people treated by the National Health Service were considered to have (1) a serious condition, and (2) a non-serious condition, in the last year for which figures are available.
	tabling member printed	The Earl of Courtown
	uin	HL751
	answer	answer is ministerial correction date of answer 09/07/2014 answer text <p>No nationally agreed definitions of serious and non-serious conditions exist in order to quantify how many people treated by the National Health Service have such conditions.</p> answering member printed Earl Howe question first answered 09/07/2014 15:16:05 answering member 2000 label Biography information for Earl Howe
	tabling member	3359 label Biography information for The Earl of Courtown

61494

	registered interest
	date	11/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Antibiotics
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what has been the total antibiotic use for (1) human medicine in general practice, (2) human medicine in hospitals, and (3) veterinary medicine, for each year since 2004.
	tabling member printed	The Countess of Mar
	uin	HL272
	answer	answer is ministerial correction date of answer 19/06/2014 answer text <p>The following table provides information on the number of dispensed prescription items for human antibiotic medicines, in the community, for the period 2004 to 2013.</p><p> </p><table><tbody><tr><td colspan="2"><p>Number of prescription items for antibiotic medicines written in the United Kingdom and dispensed, in the community, in England <sup>1, 2</sup></p></td></tr><tr><td><p>Year</p></td><td><p>Items (000s)</p></td></tr><tr><td><p>2004</p></td><td><p>33,119.0</p></td></tr><tr><td><p>2005</p></td><td><p>33,825.7</p></td></tr><tr><td><p>2006</p></td><td><p>33,627.5</p></td></tr><tr><td><p>2007</p></td><td><p>35,429.1</p></td></tr><tr><td><p>2008</p></td><td><p>34,801.3</p></td></tr><tr><td><p>2009</p></td><td><p>34,182.9</p></td></tr><tr><td><p>2010</p></td><td><p>35,302.0</p></td></tr><tr><td><p>2011</p></td><td><p>35,333.7</p></td></tr><tr><td><p>2012</p></td><td><p>37,307.0</p></td></tr><tr><td><p>2013</p></td><td><p>35,429.1</p></td></tr></tbody></table><p><em>Sources</em>:</p><p>Prescription Cost Analysis (PCA) system. The Health &amp; Social Care Information Centre, Prescribing and Primary Care Services.</p><p><em> </em></p><p><em>Notes</em>:</p><p><sup>1. </sup>As classified within British National Formulary (BNF) paragraphs 5.1.1 <em>Penicillins</em>, 5.1.2 <em>Cephalosporins, carbapenems, and other beta-lactams</em>, 5.1.3 <em>Tetracyclines</em>, 5.1.4 <em>Aminoglycoside</em>s, 5.1.5 <em>Macrolides</em>, 5.1.6 <em>Clindamycin,</em>5.1.7 <em>Some other antibacterials</em>, 5.1.11 <em>Metronidazole and tinidazole, </em>5.1.12 <em>Quinolones</em>.</p><p><sup>2. </sup>Prescriptions include those written by general practitioners, nurses, pharmacists and other non-medical prescribers.</p><p> </p><p>In terms of human antibiotic medicines used in hospitals in England, it is not possible to provide reliable information. Within hospital data, information is reported as ‘packs', a measure which is not consistent over time or for aggregation, as one pack could refer to a single vial or to a box of 10 vials, or a bottle of capsules. Therefore to sum all the packs for a range of medicines is inappropriate and any resulting figures will be misleading.</p><p> </p><p>The following table provides information on the volume of antimicrobial sales from Market Authorisation Holders for veterinary medicine.</p><p> </p><table><tbody><tr><td colspan="2"><p>Sales of animal antibiotics within the United Kingdom <sup>1, 2, 3</sup></p></td></tr><tr><td><p>Year</p></td><td><p>Tonnes of active ingredient</p></td></tr><tr><td><p>2004</p></td><td><p>453</p></td></tr><tr><td><p>2005</p></td><td><p>446</p></td></tr><tr><td><p>2006</p></td><td><p>405</p></td></tr><tr><td><p>2007</p></td><td><p>387</p></td></tr><tr><td><p>2008</p></td><td><p>384</p></td></tr><tr><td><p>2009</p></td><td><p>402</p></td></tr><tr><td><p>2010</p></td><td><p>447</p></td></tr><tr><td><p>2011</p></td><td><p>346</p></td></tr><tr><td><p>2012</p></td><td><p>409</p></td></tr></tbody></table><p><em>Sources</em>:</p><p>The Veterinary Medicines Directorate, Department for Environment, Food and Rural Affairs</p><p><em> </em></p><p><em>Notes:</em></p><p><sup>1. </sup>It is not currently possible to separate the sales data by country and hence the data provided is for the UK.</p><p><sup>2. </sup>Sales data was provided voluntarily by veterinary pharmaceutical companies from 1998-2004. Data from 2005 onwards has been collected as a statutory requirement, as set out in the Veterinary Medicines Regulations.</p><p><sup>3. </sup>2013 data will be published later in the year.</p><p> </p> answering member printed Earl Howe question first answered 19/06/2014 11:52:16 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

61942

	registered interest
	date	16/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patient Choice Schemes
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether patients have the legal right to be referred to any hospital provider of their choice, no matter where the consultant is located in England, subject to the provisos listed on the NHS website under Choosing your Hospital; whether patients diagnosed with chronic fatigue syndrome/myalgic encephalopathy in Sussex and elsewhere have been denied the opportunity to do so by local clinical commissioning groups when their general practitioners request a referral; and, if so, why.
	tabling member printed	The Countess of Mar
	uin	HL360
	answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>The 2014-15 Choice Framework and the NHS Constitution, both available on .gov.uk, set out when patients have legal rights to choice.</p><p> </p><p>The NHS Constitution states that patients have the rightto make choices about the services commissioned by National Health Service bodies and to information to support these choices.</p><p> </p><p>The 2014-15 NHS Choice Framework establishes that if a patient needs to see a consultant or specialist as an outpatient for a physical or mental health condition, they can choose the organisation that provides their NHS care and treatment anywhere in England for their first outpatient appointment. They can also choose which consultant-led team or which mental health team led by a named health care professional will be in charge of their NHS care and treatment for their first outpatient appointment.</p><p> </p><p>The organisation can be any clinically appropriate health service provider with whom any clinical commissioning group or NHS England has a commissioning contract for the service required as a result of the referral, but the team must be clinically appropriate and led by a named consultant or health professional who is employed or engaged by that health service provider.</p><p> </p><p>There are also times that patients are not able to make a choice, and these are outlined in the <em>Choice Framework</em> and the <em>Handbook to the NHS Constitution</em>. For example, patients can only choose a hospital or clinic that offers the right treatment and care for their condition. Furthermore, if patients need urgent or emergency treatment, they cannot choose who they see.</p><p> </p><p>If a patient, who is not covered by the exemptions, has not been offered choice, or denied the opportunity to exercise choice by a clinical commissioning group, the 2014-15 Choice Framework sets out a clear complaints procedure.</p> answering member printed Earl Howe question first answered 24/06/2014 12:45:48 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

63785

	registered interest
	date	24/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Advisory Bodies
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government which advisory committees provide advice on chemicals, toxicology and endocrinology; how they are funded; and what each committee costs per annum.
	tabling member printed	The Countess of Mar
	uin	HL569
	answer	answer is ministerial correction date of answer 08/07/2014 answer text <p>There are a number of Scientific Advisory Committees that provide advice to Government on chemicals, toxicology and endocrinology. They are listed as follows.</p><p> </p><p>The Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment provides advice to the Food Standards Agency, the Department of Health, Public Health England, and other Government departments and agencies on matters concerning the toxicity of chemicals. The costs of meetings are met by the Food Standards Agency, which comes to a total cost of around £35,000 per annum.</p><p> </p><p>The Committee on Carcinogenicity is an expert scientific committee of the Department that provides expert advice on matters concerning the potential carcinogenicity of chemicals, ranging from natural products to new synthetic chemicals used in pesticides or pharmaceuticals. The costs of its meetings are met by Public Health England including travel costs for members and fees, at a total cost of around £10,000 per annum.</p><p> </p><p>The Committee on Mutagenicity is an independent advisory committee that provides advice to Government departments and agencies on matters concerning the potential mutagenicity of chemicals, ranging from natural products to new synthetic chemicals used in pesticides or pharmaceuticals. The costs of its meetings are met by Public Health England including travel costs for members and fees, at a total cost of around £10,000 per annum.</p><p> </p><p>The Committee on the Medical Effects of Air Pollutants (COMEAP) is an expert scientific committee of the Department that provides expert advice on the effects on health of both outdoor and indoor air pollutants on the basis of currently available data. The costs of its meetings are met by Public Health England, including travel costs and fees for members, at a total cost of around £14,000 per annum.</p><p> </p><p>The Hazardous Substances Advisory Committee is an expert scientific committee of the Department for Environment, Food and Rural Affairs (DEFRA) that provides expert advice on how to protect the environment, and human health via the environment, from potentially hazardous substances. The costs of its meetings are met by DEFRA at a total cost of around £30,000 per annum.</p><p> </p><p>The Advisory Committee on Toxic Substances advises the Health and Safety (HSE) Executive Board on matters relating to the prevention, control and management of hazards and risks to the health and safety of persons arising from the supply or use of toxic substances at work, with due regard to any related risks to consumers, the public and the environment. Funding for the committee comes from HSE and four meetings in total in the last three years have cost £2,000.</p><p> </p> answering member printed Earl Howe question first answered 08/07/2014 15:26:20 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

77264

	registered interest
	date	10/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Lyme Disease
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government when the testing of the cerebrospinal fluid of patients suspected of having Lyme disease using the Trinity Biotech kit at the Health Protection Agency’s Lyme Borreliosis Unit began; how many patients' samples were tested in that way; and how many patients were recorded as being positive over that period of time.
	tabling member printed	The Countess of Mar
	uin	HL998
	answer	answer is ministerial correction date of answer 24/07/2014 answer text <p>The Trinity Biotech blot has been in use since 2007 by the former Health Protection Agency's Lyme Borreliosis Unit for testing cerebrospinal fluid (CSF) and proved very reliable. It has also been used in this way by other laboratories in Europe. However, CSF antibodies will not be present if there is no evidence of any other antibodies in the serum. Data is not collected centrally on specific samples from patients as the final diagnosis is made by the clinician on the basis of the test results and the clinical presentation.</p> answering member printed Earl Howe question first answered 24/07/2014 12:31:17 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar